“This stock’s gonna pop, bro. Look at the catalyst calendar. You got phase three Parkinson’s data in Q-four, phase three PHN data in Q-one, and phase two-b Huntington’s data next summer. Even if they don’t hit all three — in my opinion they will, I’ve got a combine…
Keep reading with a 7-day free trial
Subscribe to Field Research to keep reading this post and get 7 days of free access to the full post archives.